-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Hold on Amgen, Raises Price Target to $380

Benzinga·10/07/2026 15:07:02
Truist Securities analyst Gregory Renza maintains Amgen (NASDAQ:AMGN) with a Hold and raises the price target from $362 to $380.